As a consortium, we will provide a comprehensive molecular and cellular analysis of human atherosclerotic lesions, that will result in a revised and refined definition of the atherosclerotic lesion at risk for rupture.
Our network is characterized by a track record of inter-member collaborative efforts.
This program will further sustain these collaborations and synergistically utilize the available knowledge in the different research fields.
The already operational PlaqOmics network has previously identified potential key genes expressed by SMCs that relate to plaque destabilization, and stabilization.
Existing networking between the EU and American partners. Green line: joint grants, orange line: joint publications, and black line: exchange of personnel.